Nielsen Søren Saxmose, Alvarez Julio, Bicout Dominique Joseph, Calistri Paolo, Canali Elisabetta, Drewe Julian Ashley, Garin-Bastuji Bruno, Gonzales Rojas José Luis, Gortázar Schmidt Christian, Herskin Mette, Michel Virginie, Miranda Chueca Miguel Ángel, Padalino Barbara, Pasquali Paolo, Sihvonen Liisa Helena, Spoolder Hans, Ståhl Karl, Velarde Antonio, Viltrop Arvo, Winckler Christoph, De Clercq Kris, Gubbins Simon, Klement Eyal, Stegeman Jan Arend, Antoniou Sotiria-Eleni, Aznar Inma, Broglia Alessandro, Papanikolaou Alexandra, Van der Stede Yves, Zancanaro Gabriele, Roberts Helen Clare
EFSA J. 2021 Jun 8;19(6):e06632. doi: 10.2903/j.efsa.2021.6632. eCollection 2021 Jun.
EFSA received a mandate from the European Commission to assess the effectiveness of some of the control measures against diseases included in the Category A list according to Regulation (EU) 2016/429 on transmissible animal diseases ('Animal Health Law'). This opinion belongs to a series of opinions where these control measures will be assessed, with this opinion covering the assessment of control measures for foot and mouth disease (FMD). In this opinion, EFSA and the AHAW Panel of experts review the effectiveness of: i) clinical and laboratory sampling procedures, ii) monitoring period and iii) the minimum radius of the protection and surveillance zones, and the minimum length of time the measures should be applied in these zones. The general methodology used for this series of opinions has been published elsewhere; nonetheless, the transmission kernels used for the assessment of the minimum radius of the protection zone of 3 km and of the surveillance zone of 10 km are shown. Several scenarios for which these control measures had to be assessed were designed and agreed prior to the start of the assessment. The monitoring period of 21 days was assessed as effective, and it was concluded that the protection and the surveillance zones comprise > 99% of the infections from an affected establishment if transmission occurred. Recommendations, provided for each of the scenarios assessed, aim to support the European Commission in the drafting of further pieces of legislation, as well as for plausible ad hoc requests in relation to FMD.
欧洲食品安全局（EFSA）收到欧盟委员会的一项任务授权，要求其根据关于可传播动物疾病的（欧盟）2016/429号法规（《动物卫生法》），评估针对A类清单中所列疾病的一些控制措施的有效性。本意见属于将对这些控制措施进行评估的一系列意见之一，本意见涵盖对口蹄疫（FMD）控制措施的评估。在本意见中，EFSA和动物卫生与福利专家组审查了以下方面的有效性：i）临床和实验室采样程序；ii）监测期；iii）保护和监测区的最小半径，以及这些措施应在这些区域应用的最短时间。用于这一系列意见的一般方法已在其他地方发表；尽管如此，仍展示了用于评估3公里保护区域和10公里监测区域最小半径的传播核心。在评估开始之前，设计并商定了必须对这些控制措施进行评估的若干情景。21天的监测期被评估为有效，并且得出结论，如果发生传播，保护和监测区包含了来自受影响场所>99%的感染。针对所评估的每个情景提出的建议，旨在支持欧盟委员会起草进一步的立法，以及应对与口蹄疫相关的合理临时请求。
